These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 7576749

  • 1. The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma.
    Gudmundsson TE, Högberg T, Alm P, Anderson H, Baldetorp B, Fernö M, Långström E, Killander D.
    Acta Oncol; 1995; 34(6):803-12. PubMed ID: 7576749
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
    Pfisterer J, Kommoss F, Sauerbrei W, Rendl I, Kiechle M, Kleine W, Pfleiderer A.
    Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
    [Abstract] [Full Text] [Related]

  • 3. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators.
    Malmström H, Schmidt H, Persson PG, Carstensen J, Nordenskjöld B, Simonsen E.
    Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G, Gafà R, Santini A, Maestri I, Dubini A, Gilli G, Cavazzini L.
    Cancer; 1998 Jan 01; 82(1):49-59. PubMed ID: 9428479
    [Abstract] [Full Text] [Related]

  • 5. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
    Arnerlöv C, Emdin SO, Lundgren B, Roos G, Söderström J, Bjersing L, Norberg C, Angquist KA.
    Cancer; 1992 Oct 01; 70(7):1935-42. PubMed ID: 1525769
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
    Salud A, Porcel JM, Raikundalia B, Camplejohn RS, Taub NA.
    J Surg Oncol; 1999 Nov 01; 72(3):167-74. PubMed ID: 10562364
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.
    Breast Cancer Res Treat; 2005 May 01; 91(1):61-71. PubMed ID: 15868432
    [Abstract] [Full Text] [Related]

  • 10. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma.
    Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S.
    Oncology; 1996 May 01; 53(3):182-91. PubMed ID: 8643219
    [Abstract] [Full Text] [Related]

  • 11. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS, Gersell DJ, Yim S.
    Gynecol Oncol; 2001 Jun 01; 81(3):466-76. PubMed ID: 11371140
    [Abstract] [Full Text] [Related]

  • 12. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
    Vesalainen S, Nordling S, Lipponen P, Talja M, Syrjänen K.
    Br J Cancer; 1994 Aug 01; 70(2):309-14. PubMed ID: 8054280
    [Abstract] [Full Text] [Related]

  • 13. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S, Lee AK, Tahan SR, Figoni MA, Wiley BD, Heatley GJ, Silverman ML.
    Cancer; 1992 Oct 01; 70(7):1943-50. PubMed ID: 1525770
    [Abstract] [Full Text] [Related]

  • 14. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE, André S, Soares J.
    J Clin Pathol; 1999 Aug 01; 52(8):604-11. PubMed ID: 10645231
    [Abstract] [Full Text] [Related]

  • 15. Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer.
    Proctor L, Pradhan M, Leung S, Cheng A, Lee CH, Soslow RA, Gilks CB, Talhouk A, McAlpine JM, Danielsen HE, Hoang LN.
    Gynecol Oncol; 2017 Sep 01; 146(3):596-602. PubMed ID: 28647100
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic significance of ploidy and S-phase fraction in primary intraoral squamous cell carcinoma and their corresponding metastatic lymph nodes.
    El-Deftar MF, El Gerzawi SM, Abdel-Azim AA, Tohamy SM.
    J Egypt Natl Canc Inst; 2012 Mar 01; 24(1):7-14. PubMed ID: 23587227
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.
    Kaern J, Tropé CG, Kristensen GB, Tveit KM, Pettersen EO.
    Am J Obstet Gynecol; 1994 Feb 01; 170(2):479-87. PubMed ID: 8116701
    [Abstract] [Full Text] [Related]

  • 19. Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma.
    Pinto AE, Chaves P, Fidalgo P, Oliveira AG, Leitão CN, Soares J.
    Dis Colon Rectum; 1997 Apr 01; 40(4):411-9. PubMed ID: 9106689
    [Abstract] [Full Text] [Related]

  • 20. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
    Fisher B, Gunduz N, Costantino J, Fisher ER, Redmond C, Mamounas EP, Siderits R.
    Cancer; 1991 Oct 01; 68(7):1465-75. PubMed ID: 1893345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.